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Abstract
Background: In the past ten years there has been a growing interest in engineering Gram-positive
bacteria for biotechnological applications, including vaccine delivery and production of recombinant
proteins. Usually, bacteria are manipulated using plasmid expression vectors. The major limitation of this
approach is due to the fact that recombinant plasmids are often lost from the bacterial culture upon
removal of antibiotic selection. We have developed a genetic system based on suicide vectors on
conjugative transposons allowing stable integration of recombinant DNA into the chromosome of
transformable and non-transformable Gram-positive bacteria.
Results: The aim of this work was to select a strong chromosomal promoter from Streptococcus gordonii
to improve this genetic system making it suitable for expression of single-copy recombinant genes. To
achieve this task, a promoterless gene encoding a chloramphenicol acetyltransferase (cat), was randomly
integrated into the S. gordonii chromosome and transformants were selected for chloramphenicol
resistance. Three out of eighteen chloramphenicol resistant transformants selected exhibited 100%
stability of the phenotype and only one of them, GP215, carried the cat gene integrated as a single copy.
A DNA fragment of 600 base pairs exhibiting promoter activity was isolated from GP215 and sequenced.
The 5' end of its corresponding mRNA was determined by primer extention analysis and the putative -10
and a -35 regions were identified. To study the possibility of using this promoter (PP) for single copy
heterologous gene expression, we created transcriptional fusions of PP with genes encoding surface
recombinant proteins in a vector capable of integrating into the conjugative transposon Tn916. Surface
recombinant proteins whose expression was controlled by the PP promoter were detected in Tn916-
containing strains of S. gordonii and Bacillus subtilis after single copy chromosomal integration of the
recombinant insertion vectors into the resident Tn916. The surface recombinant protein synthesized
under the control of PP was also detected in Enterococcus faecalis after conjugal transfer of a recombinant
Tn916 containing the transcriptional fusion.
Conclusion: We isolated and characterized a S. gordonii chromosomal promoter. We demonstrated that
this promoter can be used to direct expression of heterologous genes in different Gram-positive bacteria,
when integrated in a single copy into the chromosome.
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Background
In the past ten years there has been a growing interest in
engineering Gram-positive bacteria for biotechnological
applications, including vaccine delivery. [1-4], and in situ
production of anti-infective protectants [5] and microbi-
cides [6]. A common approach to genetic manipulation of
bacteria is based on the use of plasmid expression vectors
since these recombinant molecules can be introduced into
bacterial cells by a variety of genetic techniques such as
natural transformation, artificial transformation, trans-
duction, conjugative mobilization, and electroporation
[7-9]. However, the major limitation of this approach is
due to the fact that recombinant plasmids are often lost
from the bacterial culture upon removal of antibiotic
selection. Certainly, this has consequences when using
recombinant bacteria in vivo where their replication
occurs in the absence of selection. An alternative approach
is to integrate recombinant DNA molecules into the bac-
terial chromosome since this method allows increased in
vivo stability of the genetic constructs. Therefore a lot of
efforts have focused on the development of efficient
expression systems based on chromosomal integration of
expression cassettes [10,11]. Naturally transformable bac-
teria represent a convenient model, since heterologous
DNA can be easily integrated into their chromosomes,
whereas genetic manipulation of non-transformable bac-
teria is more difficult and relies mainly on electroporation
and conjugative mobilization of foreign DNA molecules.
We have previously described a genetic system based on
conjugative transposons allowing stable integration of
recombinant DNA into the chromosome of transformable
and non-transformable streptococci [12,13]. A series of
transposon insertion vectors containing two regions of
homology with Tn916 [14] have been created in order to
manipulate both naturally transformable and non-trans-
formable Gram-positive bacteria carrying Tn916 [12]. The
aim of this work was to select a strong promoter to
improve this genetic system making it suitable for expres-
sion of single-copy recombinant genes in a broad spec-
trum of Gram-positive bacteria.
Results and discussion
Promoter selection by chromosomal integration
To select resident promoters from the genome of Strepto-
coccus gordonii, we performed a random ligation of strep-
tococcal DNA to a promoterless cat  gene, conferring
resistance to chloramphenicol (Cm). The ligation mixture
was used to transform the naturally transformable S. gor-
donii  «Challis» strain V288 and transformants were
selected for Cm resistance. Chromosomal DNA flanking
the promoterless cat gene provided the homology for the
random integration of cat into the chromosome during
transformation (Fig. 1). 71 Cm-resistant (CmR) trans-
formants were isolated, presumably as a result of tran-
scriptional fusions of streptococcal promoters to the
promoterless cat gene. Eighteen CmR transformants were
selected for further characterization. The strategy com-
monly used to select promoters is based on cloning ran-
dom chromosomal DNA fragments in a promoter probe
vector upstream of a promoterless reporter gene. How-
ever, integrating the promoterless reporter gene (cat)
directly into the streptococcal chromosome, allowed us to
select resident chromosomal promoters expressing cat
after in vivo transcriptional fusion at a single locus on the
chromosome. This is preferable when looking for promot-
ers to express heterologous genes integrated into the chro-
mosome in a single copy.
In vivo analysis of promoter strength was determined in
the eighteen selected transformants by measuring the
minimum inhibitory concentration (MIC) of Cm. Fifteen
transformants exhibited a MIC of 16 µg/ml, whereas the
remaining three transformants exhibited a MIC of 8 µg/
ml. The fifteen strains with higher MIC were tested for the
stability of the chloramphenicol-resistance phenotype:
after 50 generations of growth without selection, bacterial
cultures were plated on non-selective medium and at least
200 colonies were picked and tested for Cm resistance.
The stability of the resistance phenotype varied consider-
ably among the different transformants (data not shown).
Three strains (GP214, GP215 and GP216) showed a
100% stability and were chosen for further analysis.
Cloning of a promoter from S. gordonii
The structure of the integrated cat gene in GP214, GP215
and GP216 was analyzed by Southern blot. Only GP215
showed to have a single cat copy integrated into the chro-
mosome, whereas in GP214 and GP216 integration
occurred at multiple sites (data not shown). In order to
clone the regions flanking cat integration site in GP215,
the chromosome of this strain was cut with TaqI whose
recognition sequence is absent inside the cat gene. The
derivative fragments were ligated to pBLUESCRIPT, and
the ligation mixture was used to transform Escherichia coli
cells; transformants were then selected for CmR. All trans-
formants analyzed for plasmid content showed to carry a
plasmid of the same size. One of these transformants
(GP334) was selected for further analysis and the trans-
forming plasmid was named pVMB5. By restriction anal-
ysis we showed that pVMB5 contains a 2.2 kb TaqI insert
where a 600 base pairs (bp) streptococcal DNA fragment
was cloned upstream of the cat gene. This DNA fragment
was stably maintained in E. coli, where it retained its pro-
moter activity, conferring CmR to E. coli. This is of consid-
erable interest since it is known that very often cloning
streptococcal promoters in a high copy number plasmid
results in the failure of that plasmid to be established [15].BMC Biotechnology 2005, 5:3 http://www.biomedcentral.com/1472-6750/5/3
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Sequence analysis
The streptococcal DNA upstream of the cat gene in pVMB5
was sequenced (GenBank accession number: U74080).
Analysis of the sequence revealed the presence of an open
reading frame (ORF1), preceded by a typical ribosome
binding site (RBS) (Fig. 2). A BLAST search with the partial
sequenced genome of S. gordonii http://www.tigr.org/
index.shtml showed that ORF1 represents the 5'-end of a
gene encoding the first 48 amino acids (aa) of an unchar-
acterized protein conserved in bacteria and whose func-
tion is unknown. As indicated in figure 2, this truncated
streptococcal protein is translationally fused to the N-ter-
minus of CAT. Sequence analysis also revealed that the
first 122 bp of the cloned streptococcal fragment belong
to the 3'-end of a gene encoding a putative acetyltrans-
ferase (ORF2). To obtain information about the chromo-
somal region containing the 600 bp streptococcal DNA
fragment cloned in pVMB5, we looked throughout the
whole contig sequence and we found out that upstream
ORF2, and partially overlapping with it, there is an ORF
encoding a DltD horthologue (dltD), a protein involved
in D-alanine incorporation into lipoteichoic acid (LTA)
[16], whereas downstream ORF1, there is a gene encoding
a Tmp7 transmembrane protein (Fig. 2).
Identification of the transcriptional start site
To identify the sequences responsible for the observed
promoter activity, the 5'-end of the cat-specific mRNA was
In vivo transcriptional fusion by integration of a promoterless cat gene into the chromosome of a naturally transformable  streptococcus Figure 1
In vivo transcriptional fusion by integration of a promoterless cat gene into the chromosome of a naturally 
transformable streptococcus. A promoterless cat gene is ligated in vitro to random chromosomal fragments, using a restric-
tion site a few base pairs upstream of its translation initiation codon (a). The ligation mixture is then used to transform the 
recipient strain (b), and the homologous sequences allow chromosomal integration of the promoterless cat gene (c). By this 
process, the cat gene is integrated into the chromosome between two direct repeats. Since some of the chromosomal frag-
ments contain promoters (P), it is possible to obtain expression of the promoterless cat gene after in vivo transcriptional fusion 
with resident chromosomal promoters.
(a)
(b)
P cat
P P
P
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mapped by primer extension with a specific primer. Total
RNA was isolated from E. coli GP334 (containing pVMB5)
and S. gordonii GP215. In both strains, the position of the
5'-end of the mRNA was located at the same purine resi-
due at position 423 of the 600 bp region of streptococcal
DNA, 26 nucleotides upstream of the ORF1 translational
start site (Fig. 2 and 3). Putative -35 and -10 sequences
closely resembling the consensus E. coli σ70 and Bacillus
subtilis σ43 [17] recognition sequences TTGACA (-35) and
TATAAT (-10) could be identified. The -35 region was
TTGCAA, and the -10 region was TAGAAT. The spacing
between the -35 and -10 region was 17 bp and was thus
similar to the spacing in B. subtilis (17 to 19 bp) and E. coli
(16 to 18 bp) promoters. Moreover, a TG nucleotide pair
was found 1 bp upstream of the -10 region; such a struc-
ture is typical of Gram-positive bacteria promoters [18].
Based on this information, we concluded that indeed we
isolated a streptococcal promoter which was designated
PP. The spacing between the 5'-end of the mRNA and the
-10 hexanucleotide was only 2 bp, which is unusually
short. A second putative -10 region could be identified in
the TATGAT hexanucleotide (Fig. 2), whose distance from
the 5' end of the mRNA is 7 bp. However, since this
sequence is not preceded by the TG nucleotide pair typical
Schematic representation of the S. gordonii locus containing PP promoter Figure 2
Schematic representation of the S. gordonii locus containing PP promoter. DltD orthologue, an ORF encoding a 
putative acetyltransferase (ORF2), ORF1, the gene encoding a Tmp7 transmembrane protein, and the cat gene are indicated by 
arrows. Dashed arrows designate that the ORF is only partially represented in the scheme. The 600 bp TaqI-HindIII fragment 
including PP promoter and cloned upstream of the cat gene in pVMB5 is indicated by a dotted box. Nucleotide sequence of the 
PP promoter region (332 bp) is reported inside the box. The transcriptional start site determined by primer extention analysis 
is marked with an asterisk. Proposed -35 and -10 regions are underlined. A second putative -10 sequence is overlined. ORF1 
putative ribosome binding site (RBS) is boxed. ATG initiation codon of cat is in bold characters and the sequence of HindIII site 
is in italic letters. The complete sequence of the 600 bp cloned fragment is available on GenBank (Accession number: U74080). 
T, TaqI site; B, BamHI site; H, HindIII site ; loop, putative transcriptional terminator.
AAAATAGGATAAAAGGGAGAGAAAATTCGGAAATAATATGGGTGAAAAGTATATTTTCAAAAAAAATGTATAAAATTCACAGAAAATCGTTGCAA
TGAAATATTTCTTATGATAGAATATACAAAACAAATAAAAAGGAGAACGTT ATG GCT CGG ATT AAA TTA ACT CCA GAA GAA TTG 
CGT GCT TCA GCG CAA CGT TAC ACA GAT GGT GCA GAA AAT GTG AAT CAA GTT CTT TCA TCT CTT ACG AAT GAA 
CAA GCG ATC ATT TCT GAA AAC TGG GAA GGT TCA GCC TTC CAA AGC TTG GCG AGA TTT TCA GGA GCT AAG GAA 
GCT AAA ATG
T
cat
H
100 bp
dltD
-35
-10 -10 *
RBS
HindIII
ORF1
ORF2    ORF1    Tmp7   
GenBank n. U74080
BTBMC Biotechnology 2005, 5:3 http://www.biomedcentral.com/1472-6750/5/3
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of Gram-positive promoters, and is separated from the -35
region only by 12 bp, we suppose that this -10 region of
PP is probably not active.
Insertion vectors to express heterologous proteins
We have previously developed a genetic system based on
the use of Streptococcus pyogenes surface fibrillar M6 pro-
tein, as a partner for the construction of translational
fusions to deliver foreign proteins on the surface of S. gor-
donii [10]. To determine the possibility of using PP for
chromosomal single copy heterologous gene expression
in Gram-positive bacteria, we first generated a transcrip-
tional fusion of PP with a promoterless gene encoding the
M6 protein (emm6) in pSMB47, a suicide vector capable
of integrating heterologous DNA into the conjugative
transposon Tn916 via homologous recombinantion [12].
The recombinant plasmid was named pSMB139 (see
Methods) (Fig. 4). To construct a Tn916 insertion vector
that could be used to express translational fusions
between M6 and any heterologous proteins under the PP
promoter control, a 900 bp AvrII-HindIII fragment inter-
nal to emm6 in pSMB139 was replaced by a 390 bp AvrII-
HindIII fragment of pSMB55 containing a multiple clon-
ing site [10] (Fig. 4). The resulting vector, named
pSMB148 (Fig. 4), allows to create translational fusions of
heterologous proteins between the first 122 N-terminal aa
and the last 140 aa of the M6 protein, which provides
sequences necessary for cell wall anchoring.
pSMB148 was used to create two derivative vectors in
which the emm6 gene was fused respectively with a DNA
sequence encoding 339 aa of the chicken ovalbumin
(OVA) (pSMB156), and a DNA sequence encoding 458 aa
of the tetanus toxin fragment C (TTFC) (pSMB288) (see
Methods). A schematic representation of the recombinant
proteins is shown in Fig. 5A.
Expression of recombinant proteins in Gram-positive 
bacteria
S. gordonii, B. subtilis, and Enterococcus faecalis were three
Gram-positive hosts used to analyze the capability of PP
to direct transcription of the heterologous genes express-
ing M6, M6/TTFC and M6/OVA recombinant proteins.
Expression of M6 in S. gordonii
pSMB139, bearing a transcriptional fusion of PP with
emm6, was introduced by natural transformation in S. gor-
donii GP201, a strain with a single copy of Tn916 inte-
grated into the chromosome. One of the transformants
(GP1241), in which the integrative suicide vector drove
the integration of the PP-emm6 fusion into Tn916, was
isolated and analyzed for M6 protein expression. Enve-
lope fractions (containing surface associated proteins)
prepared from equal amounts of cells grown to mid-log,
early and late stationary phase, were analyzed by Western-
Primer extension analysis of the PP promoter Figure 3
Primer extension analysis of the PP promoter. Locali-
zation by primer extension of the transcriptional start site of 
the cat mRNA specified by the PP promoter in E. coli GP334 
(lanes 1–2), and S. gordonii GP215 (lanes 3–4). The sequence 
of the region upstream of the cat gene in pVMB5 was used as 
standard. The A residue, complementary to the T at position 
423, indicated by an arrow, represents the transcriptional 
start site used in both strains.BMC Biotechnology 2005, 5:3 http://www.biomedcentral.com/1472-6750/5/3
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Construction of the insertion plasmid pSMB148 Figure 4
Construction of the insertion plasmid pSMB148. pSMB139 was constructed by introducing a 2.0 kb fragment, containing 
a transcriptional fusion of PP promoter with emm6, in the Tn916 insertion vector pSMB47 (see Methods). pSMB148 is a deriv-
ative of pSMB139 in which a 900 bp AvrII-HindIII fragment was replaced with a 390 bp AvrII-HindIII fragment from pSMB55 con-
taining a multiple cloning site [10].
KpnI
XbaI
BglII
EcoRV
SalI
EcoRI
HindIII
HindIII
EcoRI
SalI
EcoRV
BglII
XbaI
KpnIBMC Biotechnology 2005, 5:3 http://www.biomedcentral.com/1472-6750/5/3
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blotting with an anti-M6 monoclonal antibody. Multiple
bands could be detected in fractions of cells grown to mid-
log and early stationary phase, whereas no band was
detected in the fraction of cultures grown to late stationary
phase (Fig. 6A). The intensity of the signal was higher dur-
ing the mid-log growth phase suggesting that either PP is
more active during exponential growth or that the M6
protein is being degraded during stationary phase. The
presence of multiple reactive bands of molecular masses
close to the hypothetical size of M6 (predicted molecular
weight, 49 kDa) is probably due to the fact that coiled-coil
proteins like M6 run at aberrant sizes on denaturing gels
[19].
Expression of M6/TTFC in B. subtilis
Competent cells of B. subtilis GP800.2, containing one
copy of Tn916  integrated into the chromosome, were
transformed with the insertion vector pSMB288, bearing
the transcriptional fusion PP-emm6/ttfc. One transform-
ant, GP848, was chosen for further studies. A culture of
GP848 was grown to mid-exponential phase and analyzed
by Western-blotting for the presence of recombinant M6/
TTFC. As shown in Fig. 6B, two reactive bands could be
detected in the envelope fraction. The lower band, indi-
cated by an arrow, corresponds to the mature protein
(predicted molecular weight, 82 kDa), while the upper
band probably represents an unprocessed form (predicted
molecular weight, 86.4 kDa).
Expression of M6/OVA in E. faecalis
Using a previously described genetic system [12], we con-
structed a derivative of the E. faecalis strain OG1SS [20]
expressing the recombinant M6/OVA protein under PP
control. pSMB156, bearing the PP-emm6/ova fusion, was
first introduced in the Tn916  containing  B. subtilis
GP800.2 by natural transformation, to obtain a recom-
binant conjugative transposon containing the transcrip-
tional fusion. The recombinant transposon was then
transferred by conjugation into E. faecalis OG1SS.
Transconjugants were detected at a frequency of 4 × 10-10
transconjugants/recipient. One of them (GP431) was ana-
lyzed for cell-surface expression of M6/OVA by flow-cyto-
metric analysis using an anti-ovalbumin polyclonal
antibody. The presence of recombinant M6/OVA on the
surface of GP431 was clearly demonstrated by the increase
of the fluorescence intensity in this strain, as compared to
the parental control OG1SS (Fig. 7).
Conclusions
We have isolated and characterized a promoter from the
chromosome of S. gordonii, and demonstrated that it can
be used to direct expression of heterologous genes in dif-
ferent Gram-positive bacteria when integrated in a single
copy into the chromosome. This promoter, together with
the genetic system based on suicide vectors able to inte-
grate into conjugative transposons, represents a useful
tool for the stable manipulation of a broad spectrum of
Gram-positive bacteria.
Methods
Bacterial strains, plasmids and growth conditions
All strains and plasmids used in this work are listed in
Table 1. E. coli strains DH5α and HB101 were cultured in
Luria-Bertani (LB) broth. For maintenance of plasmids,
Schematic representation of recombinant M6, M6/TTFC and M6/OVA expressed on the surface of S. gordonii, B. subtilis and E.  faecalis Figure 5
Schematic representation of recombinant M6, M6/TTFC and M6/OVA expressed on the surface of S. gordonii, 
B. subtilis and E. faecalis. The 458 aa protein TTFC (white bar) and the 339 aa protein OVA (light gray bar) were fused with 
the first 122 N-terminal aminoacids and the last 140 C-terminal aminoacids of M6 (dark gray bar). The predicted molecular 
weight of M6, M6/TTFC and M6/OVA is 49 kDa, 82 kDa and 66.9 kDa respectively.
M6
M6/TTFC
M6/OVA
122 aa 179 aa 140 aa
122 aa 458 aa 140 aa
122 aa 339 aa 140 aa
C S. gordonii
B. subtilis
E. faecalis
N
C
C N
N
TTFC
OVABMC Biotechnology 2005, 5:3 http://www.biomedcentral.com/1472-6750/5/3
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ampicillin (100 µg/ml), chloramphenicol (20 µg/ml) or
erythromycin (100 µg/ml) was added to the growth
medium. Streptococcal strains were cultured in Brain
Heart Infusion medium (BHI, Difco) or Tryptic Soy Broth
(TSB, Difco) in the presence of chloramphenicol (5 µg/
ml), erythromicin (100 µg/ml) or streptomycin (500 µg/
ml) whenever required. Transformation of naturally com-
petent cells of S. gordonii V288 and GP201, scoring and
genetic analysis of transformants was carried out as
already described [21,22]. B. subtilis strains were grown in
LB broth with erythromicin (3 µg/ml) when it was
required. Competent cells of B. subtilis GP800.2 were pre-
pared and transformed according to described procedures
[23]. Agar (1.5%) was added to LB, BHI or TSB to obtain
solid media. All cultures were incubated at 37°C.
DNA manipulation
Total DNA preparation of S. gordonii was performed as
previously described [21]. Plasmid DNA was prepared
using the Qiagen Plasmid Kit (Qiagen) according to the
manufacturer's instructions. All recombinant techniques
were performed following standard procedures [24],
using E. coli HB101 or DH5α as a host. DNA restriction
enzymes were obtained from Roche and used according to
the manufacturer's instructions.
Promoter selection by chromosomal integration
A 1.6 kb HindIII-BamHI fragment of plasmid pKT [25],
containing a cat gene, was ligated with random chromo-
somal DNA fragments of S. gordonii V288 previously cut
with both HindIII and BamHI. The initiation codon of cat
was 34 bp downstream of the HindIII site, therefore Hin-
dIII cleavage would leave cat promoterless and preceded
by an intact ribosome binding site. The ligation mixture
was introduced in S. gordonii V288 and transformants
were selected for CmR.
MIC determination
The MIC of chloramphenicol for S. gordonii was deter-
mined following standard procedures [26].
Western blot analysis of recombinant S. gordonii and B. subtilis strains expressing M6 protein and M6/TTFC fusion protein Figure 6
Western blot analysis of recombinant S. gordonii and B. subtilis strains expressing M6 protein and M6/TTFC 
fusion protein. (A) S. gordonii envelope fractions. Lane 1 through 3, GP1241 expressing M6 under the control of PP pro-
moter. Lane 1, GP1241 harvested after overnight growth. Lane 2, GP1241 harvested after early stationary phase. Lane 3, 
GP1241 harvested after exponential phase. Lane 4, recipient strain GP201 (negative control). Lane 5, GP231 (positive control). 
Blot was developed with anti-M6 monoclonal antibody 10B6. (B) S. gordonii and B. subtilis envelope fractions. Lane 1, S. gordonii 
GP204 (negative control). Lane 2, S. gordonii GP1253 expressing M6/TTFC (positive control). Lane 3, B. subtilis recipient strain 
GP800.2 (negative control). Lane 4, B. subtilis GP848 expressing M6/TTFC under the control of PP promoter. Blot was devel-
oped with anti TTFC rabbit serum. Molecular weight markers are shown in the right side of panels.
97.4 kDa
66 kDa
46 kDa
46 kDa
66 kDa
97.4 kDa
30 kDa
1    2    3    4    5 1     2     3     4
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Construction of recombinant vectors
A 1648 bp fragment containing the emm6 gene (encoding
M6, a fibrillar surface protein of S. pyogenes) was amplified
by PCR from plasmid pVMB20 [22] using the oligonucle-
otides 5'-ATGGATCCATCATATGGCTAAAAATAACAC-
GAAT-3' (upstream primer, containing a BamHI site and
introducing a NdeI site at the ATG translation initiation
codon) and 5'-GCATGTCGACCATAATCATTAAATG-
TATCTCAT-3' (downstream primers containing a SalI
site). This 1648 bp PCR fragment was digested with
BamHI and SalI and cloned in pVA891 [27] previously
digested with BamHIand  SalI, resulting in plasmid
pSMB89. A 451 bp region containing the streptococcal
promoter PP was amplified from pVMB5 using the fol-
lowing primers: 5'-CGAGGATCCTTTAATCGATACT-
CATG-3' (upstream primer, containing a BamHI and a
ClaI site) and 5'-CCGCATATGGTTCTCCTTTTTATTTGT-3'
(downstream primers containing a NdeI site). After diges-
tion with BamHI and NdeI, this PCR product was inserted
between the BamHI and NdeI site of pSMB89 to obtain a
transcriptional fusion of PP with emm6. The resulting
plasmid was named pSMB128. This plasmid was first cut
with  BamHI, treated with Klenow enzyme to generate
blunt ends, and finally cut with SalI to obtain a 2.0 kbfrag-
ment containing PP-emm6 fusion. This fragment was gel-
purified and ligated to the suicide integrative plasmid
pSMB47 [12] previously cut with HindIII, treated with Kle-
now enzyme to generate blunt ends, and finally cut with
SalI. The resulting plasmid was named pSMB139 (Fig. 4).
To introduce a multiple cloning site in the emm6 gene
contained in pSMB139, the 900 bp AvrII-HindIII fragment
internal to emm6 was replaced with the 390 bp AvrII-Hin-
dIII fragment of emm6 from pSMB55 [10] (Fig. 4). The
resulting plasmid was named pSMB148. A 1016 bp DNA
region encoding 339 aa of the chicken ovalbumin (OVA)
(Gene Bank accession number: V00383) was amplified
with the following primers: 5'-CTAGATCTGACAGCA
CCAGGACAC-3' (upstream primer containing a BglII site)
and 5'-TAAAGCTTTAGGGG AAACACATCTG-3' (down-
stream primer containing a HindIII site). After digestion
with BglII and HindIII, this segment was introduced in
pSMB148 previously digested with BglII and HindIII. The
resulting plasmid, named pSMB156, contained a transla-
tional fusion of M6 with OVA. To create a translational
fusion of M6 with the tetanus toxin fragment C (TTFC) a
1374 bp BglII-HindIII fragment encoding 458 aa of TTFC
was isolated from pSMB158 [28] and cloned between the
BglII and HindIII sites of pSMB148. The resulting plasmid
was named pSMB288.
Flow-cytometric analysis of E. faecalis expressing M6/OVA Figure 7
Flow-cytometric analysis of E. faecalis expressing M6/OVA. (A) OG1SS, recipient strain not expressing M6/OVA. (B) 
GP431, recombinant strain expressing M6/OVA on the surface. Bacterial cells were treated with anti-OVA rabbit serum and 
than with FITC-conjugated goat anti-rabbit IgG. x axis, arbitrary units (a.u.) of fluorescence intensity (log10); y axis, relative cell 
number.
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Western-blot analysis
Preparation of S. gordonii and B. subtilis cell envelope frac-
tions (representing the protoplast surface containing the
cell membrane together with cell wall fragments associ-
ated to the protoplasts) was performed as already
described [29,30]. The monoclonal antibody 10B6 [31]
diluted 1:1000 was used to detect the presence of M6 pro-
tein. M6/TTFC fusion protein was visualized with an anti-
TTFC rabbit serum (Calbiochem-Novabiochem Corpora-
tion) diluted 1:1000.
Flow-cytometric analysis
Flow-cytometric analysis of E. faecalis was performed as
already described [28,32] using an anti-OVA rabbit serum
diluted 1:300 [29].
DNA sequence determination
The promoter containing fragment cloned in pVMB5 was
sequenced by dideoxy chain termination method [33] as
already described [34]. Denatured plasmid DNA was used
as template.
RNA isolation
Total RNA was isolated from a 50 ml cell culture of S. gor-
donii and E. coli grown to late exponential phase (OD590
0.5). Cells were harvested by centrifugation at 6000 × g at
4°C and lysed according to the following procedures. E.
coli cells were first resuspended in hot (100°C) lysis buffer
(50 mM Tris/HCl pH8, 1 mM EDTA, 1% SDS) and lysed
by boiling the suspension for 5 minutes. S. gordonii cells
were resuspended in lysozyme buffer (25 mM Tris/HCl
Table 1: Strains and plasmids used in this work
Strain Relevant genotypea Source/reference
S. gordonii
V288 Recipient in transformation [35]
GP201 ΩTn5253, SmR, CmR, TcR [13]
GP204 str-204, SmR [13]
GP214 pKT random in V288, CmR This work
GP215 pKT random in V288, CmR This work
GP216 pKT random in V288, CmR This work
GP231 emm6, ErR, SmR [21]
GP1241 ΩTn5253 (∆tetM::pSMB139) ErR, SmR, CmR, TcS This work
GP1253 emm6.1::TTFC [28]
E. faecalis
OG1SS Recipient in conjugation, SmR, SpR [20]
GP431 ΩTn916, ErR, TcS (∆ tetM::pSMB156) This work
B. subtilis
GP800.2 ΩTn916, TcR [12]
GP847 ΩTn916, ErR, TcS (∆ tetM::pSMB156) This work
GP848 ΩTn916, ErR, TcS (∆ tetM::pSMB288) This work
Plasmid Description Source/reference
pKT ApR, CmR [25]
pBluescript ApR Stratagene
pVMB5 pBluescript::PP-cat, ApR, CmR This work
pVMB20 pBluescript::emm6.1::ermC, ApR, ErR [21]
pVA891 CmR, ErR [27]
pSMB47 pVA891 derivative containing DNA sequences from Tn5253, CmR, ErR [12]
pSMB89 pVA891::emm6, CmR, ErR This work
pSMB128 pVA891::PP-emm6, CmR, ErR This work
pSMB139 pSMB47::PP-emm6, CmR, ErR This work
pSMB148 pSMB47::PP-emm6/55, CmR, ErR This work
pSMB156 pSMB47::PP-emm6/55::ova, CmR, ErR This work
aSm, streptomycin; Cm, chloramphenicol; Tc, tetracyclin; Er, erythromycin; spectinomycin; Ap, ampicillin.BMC Biotechnology 2005, 5:3 http://www.biomedcentral.com/1472-6750/5/3
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(pH8), 10 mM EDTA, 50 mM glucose) and subjected to
three cycles of freezing in liquid nitrogen and thawing at
52°C. After incubating with 0.2 mg/ml of lysozyme for 30
min at 37°C, one volume of hot (100°C) lysis buffer (100
mM Tris/HCl (pH8), 2 mM EDTA, 2% SDS) was added,
and complete lysis was obtained by boiling cells for 5
minutes. After boiling, all lysates were cooled on ice for 5
min and total RNA was purified using the SV Total RNA
Isolation System (Promega).
Primer-extention analysis
Primer extention analysis was performed with a synthetic
oligonucleotide 5'-GTTCTTTACGATGCC-3' (position 47
to 61 relative to the initiation of the cat gene). Two pmol
of the oligonucleotide, labeled with [γ-32P] ATP (3000 Ci/
mmol, Amersham) using T4 polynucleotide kinase (New
England Biolabs), were precipitated with 10 µg of RNA
and the pellet was resuspended in 8 µl of Moloney Murine
Leukemia Virus (M-MuLV) Reverse Transcriptase buffer
(50 mM Tris/HCl (pH8.3), 8 mM MgCl2, 10 mM DTT).
The mixture was heated at 65°C for 3 min, cooled rapidly
at -80°C for 1 min and then transfered on ice until it was
completely thawed. 1 µl of a 3.75 mM deoxynucleoside
triphosphate solution and 10 U of M-MuLV Reverse Tran-
scriptase (New England Biolabs) were added to the RNA-
primer hybrid. The reaction mixture was incubated at
48°C for 30 min and terminated with 10 ml of stop solu-
tion (95% formamide, 20 mM EDTA pH8.0, 0.05%
bromophenol blue, and 0.05% xylene cyanol FF). The
reverse transcriptase reactions were analyzed by electro-
phoresis on a 6% polyacrylamide-7 M urea gel with
sequencing reaction obtained with the same primer used
as size standards.
Conjugation
Conjugation experiments were performed on solid media
as previously described [12].
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